{"id":"NCT00251758","sponsor":"Takeda","briefTitle":"Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn","officialTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo on Symptom Relief in Subjects With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-12","primaryCompletion":"2006-05","completion":"2006-05","firstPosted":"2005-11-10","resultsPosted":"2009-03-23","lastUpdate":"2010-05-18"},"enrollment":908,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Gastroesophageal Reflux Disease"],"interventions":[{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Dexlansoprazole MR 60 mg QD","type":"EXPERIMENTAL"},{"label":"Dexlansoprazole MR 90 mg QD","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the efficacy and safety of daily treatment with Dexlansoprazole modified release (MR) (60 mg or 90 mg once daily \\[QD\\]) compared to placebo QD in relief of daytime and nighttime heartburn over 4 weeks in subjects with gastroesophageal reflux disease (GERD).","primaryOutcome":{"measure":"Percentage of Days With Neither Daytime Nor Nighttime Heartburn During Treatment as Assessed by Daily Electronic Diary-Median","timeFrame":"4 weeks","effectByArm":[{"arm":"Placebo QD","deltaMin":17,"sd":null},{"arm":"Dexlansoprazole MR 60 mg QD","deltaMin":45.7,"sd":null},{"arm":"Dexlansoprazole MR 90 mg QD","deltaMin":52.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.00001"},{"comp":"OG000 vs OG002","p":"<0.00001"},{"comp":"OG001 vs OG002","p":"0.15505"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":18},"locations":{"siteCount":99,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://general.takedapharm.com/content/file/pi.pdf?applicationcode=9efb34b3-fb69-4190-a2be-a90b8cb94e25&filetypecode=DEXILANTPI"]},"adverseEventsSummary":{"seriousAny":{"events":0},"commonTop":["Gastrointestinal and Abdominal Pains (Excl Oral and Throat)","Upper Respiratory Tract Infections","Headaches NEC","Diarrhoea (Excl Infective)","Nausea and Vomiting Symptoms"]}}